REMEDY : BNSSG referral pathways & Joint Formulary


Home > Formulary : Paediatric > Paediatric Chapters > 2. Cardiovascular system >

BNSSG Paediatric Joint Formulary

2.5 Heart Failure

Last edited: 31-01-2024

First line drugs Second line drugs Specialist drugs Secondary care drugs

2.5 Heart Failure

Secondary Care to maintain responsibility for monitoring amber specialist initiated drugs in the cardiovascular section of the Paediatric formulary. A clear management plan detailed in the clinic letter is required to support primary care prescribing. GP Practices should ensure a plan is in place before taking over prescribing responsibility

Aldosterone Antagonists

Spironolactone (TLS Amber specialist initiated)

Potassium canrenoate (intravenous)

  • For use in NICU

 

Phosphodiesterase type-3 Inhibitors

Enoximone (TLS Red)

Milrinone (TLS Red)

 

Calcium Sensitiser

Levosimendan (TLS Red)

 

Inotropes

Dobutamine (TLS Red) 

Dopamine (TLS Red)

Metaraminol (TLS Red)

Milrinone (TLS Red)

Noradrenaline (TLS Red)

Adrenaline (TLS Red)

 

Diuretics

Loop Diuretics

Furosemide (TLS Amber specialist initiated)

  • For liquid use 50mg/5mL strength liquid

Alternative:

Bumetanide (TLS Red)